Impaired decision-making in idiopathic REM sleep behavior disorder

Sleep Medicine

Volumn 13, Issue 3, 2012, Pages 301-306

  Sasai, Taeko ^a,b,c   Miyamoto, Tomoyuki ^d   Miyamoto, Masayuki ^d   Iwanami, Masaoki ^d   Abe, Takashi ^a,b   Matsuura, Masato ^c   Inoue, Yuichi ^a,b  

^a NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Decision making; Iowa Gambling Task; Olfactory function; Parkinson disease; REM sleep behavior disorder; REM sleep without atonia

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; IDIOPATHIC DISEASE; IOWA GAMBLING TASK; JAPAN; MALE; MEDICAL DECISION MAKING; PARASOMNIA; PRIORITY JOURNAL; REM SLEEP; SCORING SYSTEM; SCREENING TEST; SMELLING; SNIFFIN STICK TEST;

AGED; COGNITION; DECISION MAKING; FATIGUE; FEMALE; GAMBLING; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER; SLEEP STAGES; SMELL;

EID: 84863394541     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.09.012     Document Type: Article

References (44)

1. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16years after its formal identification in SLEEP. Sleep 2002, 25:120-138.
2. Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123(Pt 2):331-339.
3. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Marti M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006, 5:572-577.
4. Postuma R.B., Lang A.E., Massicotte-Marquez J., Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006, 66:845-851.
5. Braak H., Rub U., Gai W.P., Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003, 110:517-536.
6. Haehner A., Hummel T., Hummel C., Sommer U., Junghanns S., Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 2007, 22:839-842.
7. Boeve B.F., Silber M.H., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 130:2770-2788.
8. Scaglione C., Vignatelli L., Plazzi G., Marchese R., Negrotti A., Rizzo G., et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci 2005, 25:316-321.
9. Burke R.E., Dauer W.T., Vonsattel J.P. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008, 64:485-491.
10. Parkkinen L., Pirttila T., Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 2008, 115:399-407.
11. Miyamoto T., Miyamoto M., Iwanami M., Hirata K., Kobayashi M., Nakamura M., et al. Olfactory dysfunction in idiopathic REM sleep behavior disorder. Sleep Med 2010, 11:458-461.
12. Janvin C., Aarsland D., Larsen J.P., Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003, 15:126-131.
13. Gagnon J.F., Vendette M., Postuma R.B., Desjardins C., Massicotte-Marquez J., Panisset M., et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009, 66:39-47.
14. Rowe J.B., Hughes L., Ghosh B.C., Eckstein D., Williams-Gray C.H., Fallon S., et al. Parkinson's disease and dopaminergic therapy - differential effects on movement, reward and cognition. Brain 2008, 131:2094-2105.
15. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
16. Mimura M., Oeda R., Kawamura M. Impaired decision-making in Parkinson's disease. Parkinsonism Relat Disord 2006, 12:169-175.
17. Cools R. Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006, 30:1-23.
18. Kobayakawa M., Koyama S., Mimura M., Kawamura M. Decision making in Parkinson's disease: analysis of behavioral and physiological patterns in the Iowa gambling task. Mov Disord 2008, 23:547-552.
19. AASM. International Classification of Sleep Disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
20. Saito S., Ayabe-Kanamura S., Takashima Y., Gotow N., Naito N., Nozawa T., et al. Development of a smell identification test using a novel stick-type odor presentation kit. Chem Senses 2006, 31:379-391.
21. Hummel T., Kobal G., Gudziol H., Mackay-Sim A. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007, 264:237-243.
22. Perretta J.G., Pari G., Beninger R.J. Effects of Parkinson disease on two putative nondeclarative learning tasks: probabilistic classification and gambling. Cogn Behav Neurol 2005, 18:185-192.
23. Pagonabarraga J., Garcia-Sanchez C., Llebaria G., Pascual-Sedano B., Gironell A., Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord 2007, 22:1430-1435.
24. Delazer M., Sinz H., Zamarian L., Stockner H., Seppi K., Wenning G.K., et al. Decision making under risk and under ambiguity in Parkinson's disease. Neuropsychologia 2009, 47:1901-1908.
25. Braak H., Rub U., Jansen Steur E.N., Del Tredici K., de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005, 64:1404-1410.
26. Euteneuer F., Schaefer F., Stuermer R., Boucsein W., Timmermann L., Barbe M.T., et al. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia 2009, 47:2882-2890.
27. Eisensehr I., Linke R., Noachtar S., Schwarz J., Gildehaus F.J., Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000, 123(Pt 6):1155-1160.
28. Eisensehr I., Linke R., Tatsch K., Kharraz B., Gildehaus J.F., Wetter C.T., et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003, 26:507-512.
29. Haber S.N., Kunishio K., Mizobuchi M., Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 1995, 15:4851-4867.
30. Terzaghi M., Sinforiani E., Zucchella C., Zambrelli E., Pasotti C., Rustioni V., et al. Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease?. Sleep Med 2008, 9:343-351.
31. Fantini M.L., Farini E., Ortelli P., Zucconi M., Manconi M., Cappa S., et al. Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder. Sleep 2011, 34:619-625.
32. Suhr J., Hammers D. Who fails the Iowa Gambling Test (IGT)? Personality, neuropsychological, and near-infrared spectroscopy findings in healthy young controls. Arch Clin Neuropsychol 2010, 25:293-302.
33. Thiel A., Hilker R., Kessler J., Habedank B., Herholz K., Heiss W.D. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Transm 2003, 110:1289-1301.
34. Stout J.C., Rodawalt W.C., Siemers E.R. Risky decision making in Huntington's disease. J Int Neuropsychol Soc 2001, 7:92-101.
35. Campbell M.C., Stout J.C., Finn P.R. Reduced autonomic responsiveness to gambling task losses in Huntington's disease. J Int Neuropsychol Soc 2004, 10:239-245.
36. Tessitore A., Hariri A.R., Fera F., Smith W.G., Chase T.N., Hyde T.M., et al. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J Neurosci 2002, 22:9099-9103.
37. Kawamura M., Kobayakawa M. Emotional impairment in Parkinson's disease. Parkinsonism Relat Disord 2009, 15(Suppl. 1):S47-52.
38. Ponsen M.M., Stoffers D., Twisk J.W., Wolters E., Berendse H.W. Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Mov Disord 2009, 24:1060-1065.
39. Ross G.W., Petrovitch H., Abbott R.D., Tanner C.M., Popper J., Masaki K., et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63:167-173.
40. Iranzo A., Lomena F., Stockner H., Valldeoriola F., Vilaseca I., Salamero M., et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 2010, 9:1070-1077.
41. Postuma R.B., Gagnon J.F., Vendette M., Desjardins C., Montplaisir J.Y. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011, 69:811-818.
42. Iranzo A., Isetta V., Molinuevo J.L., Serradell M., Navajas D., Farre R., et al. Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorder. Sleep Med 2010, 11:534-539.
43. Ibarretxe-Bilbao N., Junque C., Tolosa E., Marti M.J., Valldeoriola F., Bargallo N., et al. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009, 30:1162-1171.
44. Brand M., Labudda K., Kalbe E., Hilker R., Emmans D., Fuchs G., et al. Decision-making impairments in patients with Parkinson's disease. Behav Neurol 2004, 15:77-85.